Other GLP-1 Medications: Dulaglutide (Trulicity): Once-weekly GLP-1 agonist FDA-approved for diabetes only Not typically prescribed for weight loss Modest weight loss (3-5 kg average) Exenatide (Byetta, Bydureon): Older GLP-1 agonist Daily or weekly depending on formulation Less effective than newer options Rarely used now Oral Semaglutide (Rybelsus): Daily tablet form of semaglutide Much less effective than injectable (3-5% weight loss) Strict dosing requirements (empty stomach, wait 30 minutes) Not recommended for weight loss Side-by-Side Comparison: Which GLP-1 Should You Choose
The SELECT trial, published in 2024, showed that semaglutide reduced major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) by 20% in individuals with obesity, even independent of weight loss magnitude. Why
Why GLP-1 Users May Experience Skin Laxity One of the most common concerns among GLP-1 program users is the appearance of loose skin, especially in the face and neck
Rita Kapoor offer trusted guidance to help you determine which treatment is best suited for your health goals
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy